Dynamic changes in spatiotemporal transcriptome reveal maternal immune dysregulation of autism spectrum disorder

被引:7
|
作者
Duan, Lian [1 ,2 ]
Liu, Jiaxin [2 ]
Yin, Huamin [2 ]
Wang, Wenhang [2 ]
Liu, Li [2 ]
Shen, Jingling [2 ,4 ]
Wang, Zhendong [3 ]
机构
[1] Wenzhou Med Univ, Affiliated Hosp 1, Cent Lab, Wenzhou 325000, Peoples R China
[2] Wenzhou Univ, Chashan Univ Town, Inst Life Sci, Coll Life & Environm Sci, Wenzhou 325035, Peoples R China
[3] Wenzhou Med Univ, Affiliated Hosp 1, Key Lab Intervent Pulmonol Zhejiang Prov, Wenzhou 325000, Peoples R China
[4] Wenzhou Univ, Inst Life Sci, Coll Life & Environm Sci, Wenzhou 325035, Zhejiang, Peoples R China
关键词
Maternal immune activation; Autism spectrum disorders; Coincidence developmental window; Immune; Metabolism; ACTIVATION; PATHWAYS; EXPOSURE; MODELS; MICE;
D O I
10.1016/j.compbiomed.2022.106334
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Maternal immune activation (MIA) during pregnancy is known to be an environmental risk factor for neurodevelopment and autism spectrum disorder (ASD). However, it is unclear at which fetal brain developmental windows and regions MIA induces ASD-related neurodevelopmental transcriptional abnormalities. The nonchasm differentially expressed genes (DEGs) involved in MIA inducing ASD during fetal brain developmental windows were identified by performing the differential expression analysis and comparing the common DEGs among MIA at four different gestational development windows, ASD with multiple brain regions from human patients and mouse models, and human and mouse embryonic brain developmental trajectory. The gene set and functional enrichment analyses were performing to identify MIA dysregulated ASD-related the fetal neurodevelopmental windows and brain regions and function annotations. Additionally, the networks were constructed using Cytoscape for visualization. MIA at E12.5 and E14.5 increased the risk of distinct brain regions for ASD. MIA-driven transcriptional alterations of non-chasm DEGs, during the coincidence brain developmental windows between human and mice, involving ASD-relevant synaptic components, as well as immune- and metabolism-related functions and pathways. Furthermore, a great number of non-chasm brain development-, immune-, and metabolism-related DEGs were overlapped in at least two existing ASD-associated databases, suggesting that the others could be considered as the candidate targets to construct the model mice for explaining the pathological changes of ASD when environmental factors (MIA) and gene mutation effects co-occur. Overall, our search supported that transcriptome-based MIA dysregulated the brain development-, immune-, and metabolism-related non-chasm DEGs at specific embryonic brain developmental window and region, leading to abnormal embryonic neurodevelopment, to induce the increasing risk of ASD.
引用
收藏
页数:9
相关论文
共 50 条
  • [31] Maternal genetic effects in autism spectrum disorder
    Vucinic, Kim
    Carlisle, Catherine Mahoney
    Shields, Denis
    IRISH JOURNAL OF MEDICAL SCIENCE, 2022, 191 (SUPPL 3) : S70 - S70
  • [32] Maternal Immune Activation and Autism Spectrum Disorder: From Rodents to Nonhuman and Human Primates
    Careaga, Milo
    Murai, Takeshi
    Bauman, Melissa D.
    BIOLOGICAL PSYCHIATRY, 2017, 81 (05) : 391 - 401
  • [33] Ketogenic diet improves behaviors in a maternal immune activation model of autism spectrum disorder
    Ruskin, David N.
    Murphy, Michelle I.
    Slade, Sierra L.
    Masino, Susan A.
    PLOS ONE, 2017, 12 (02):
  • [34] Characterising the transcriptome in autism spectrum disorder using RNAseq
    Meaburn, Emma
    Saffari, Ayden
    Dudbridge, Frank
    BEHAVIOR GENETICS, 2017, 47 (06) : 679 - 679
  • [35] Transcriptome Study in Sicilian Patients with Autism Spectrum Disorder
    Salemi, Michele
    Schillaci, Francesca A.
    Lanza, Giuseppe
    Marchese, Giovanna
    Salluzzo, Maria Grazia
    Cordella, Angela
    Caniglia, Salvatore
    Bruccheri, Maria Grazia
    Truda, Anna
    Greco, Donatella
    Ferri, Raffaele
    Romano, Corrado
    BIOMEDICINES, 2024, 12 (07)
  • [36] Elevated levels of peripheral and central nervous system immune markers reflect innate immune dysregulation in autism spectrum disorder
    Szabo, Attila
    O'Connell, Kevin S.
    Akkouh, Ibrahim A.
    Ueland, Thor
    Sonderby, Ida E.
    Hope, Sigrun
    Roe, Anne B.
    Donnum, Monica S.
    Sjaastad, Ingrid
    Steen, Nils Eiel
    Ueland, Torill
    Saether, Linn Sofie
    Osete, Jordi Requena
    Andreassen, Ole A.
    Naerland, Terje
    Djurovic, Srdjan
    PSYCHIATRY RESEARCH, 2024, 342
  • [37] Mosaic Epigenetic Dysregulation of Ectodermal Cells in Autism Spectrum Disorder
    Berko, Esther R.
    Suzuki, Masako
    Beren, Faygel
    Lemetre, Christophe
    Alaimo, Christine M.
    Calder, R. Brent
    Ballaban-Gil, Karen
    Gounder, Batya
    Kampf, Kaylee
    Kirschen, Jill
    Maqbool, Shahina B.
    Momin, Zeineen
    Reynolds, David M.
    Russo, Natalie
    Shulman, Lisa
    Stasiek, Edyta
    Tozour, Jessica
    Valicenti-McDermott, Maria
    Wang, Shenglong
    Abrahams, Brett S.
    Hargitai, Joseph
    Inbar, Dov
    Zhang, Zhengdong
    Buxbaum, Joseph D.
    Molholm, Sophie
    Foxe, John J.
    Marion, Robert W.
    Auton, Adam
    Greally, John M.
    PLOS GENETICS, 2014, 10 (05):
  • [38] Changes in maternal feelings for children with autism spectrum disorder after childbirth: The impact of knowledge about the disorder
    Tomiyama, Sarah
    Kikuchi, Mitsuru
    Yoshimura, Yuko
    Hasegawa, Chiaki
    Ikeda, Takashi
    Saito, Daisuke N.
    Kumazaki, Hirokazu
    Naito, Nobushige
    Minabe, Yoshio
    PLOS ONE, 2018, 13 (08):
  • [39] Immune dysfunction and neuroinflammation in autism spectrum disorder
    Bjorklund, Geir
    Saad, Khaled
    Chirumbolo, Salvatore
    Kern, Janet K.
    Geier, David A.
    Geier, Mark R.
    Urbina, Mauricio A.
    ACTA NEUROBIOLOGIAE EXPERIMENTALIS, 2016, 76 (04) : 257 - 268
  • [40] The Role of the Immune System in Autism Spectrum Disorder
    Meltzer, Amory
    Van de Water, Judy
    NEUROPSYCHOPHARMACOLOGY, 2017, 42 (01) : 284 - 298